Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Cancer. 2016 Jan 11;122(5):730–739. doi: 10.1002/cncr.29705

Table 2.

Characteristics of survivors of childhood astroglial tumors eligible for study by vision status

Characteristic Vision without impairment (n=446) Vision with impairment (n=102) Bilateral blindness (n=39) P-value
Age at Interview [n (%)]
    <30 years 186 (41.7) 58 (56.9) 20 (51.3) 0.08
    30-39 years 205 (46.0) 34 (33.3) 16 (41.0)
    ≥40 years 55 (12.3) 10 (9.8) 3 (7.7)
Sex [n (%)]
    Male 224 (50.2) 43 (42.2) 18 (46.2) 0.32
    Female 222 (49.8) 59 (57.8) 21 (53.8)
Age at diagnosis [n (%)]
    ≤4 years 138 (30.9) 54 (52.9) 18 (46.2) <0.001
    5-9 years 105 (23.5) 18 (17.6) 11 (28.2)
    ≥10 years 203 (45.5) 30 (29.4) 10 (25.6)
Treatment*
    Surgery [n (%)]
        Yes 413 (98.8) 91 (96.8) 34 (91.9) 0.03
        No 5 (1.2) 3 (3.2) 3 (8.1)
    Chemotherapy [n (%)]
        Yes 63 (15.0) 14 (14.9) 10 (27.0) 0.17
        No 356 (85.0) 80 (85.1) 27 (73.0)
    Radiation [n (%)]
        Yes 246 (58.7) 50 (53.2) 28 (75.7) 0.06
        No 173 (41.3) 44 (46.8) 9 (24.3)
Age at first vision problem
    ≤6 years NA 56 (54.9) 17 (43.6) 0.26
    >6 years NA 46 (45.1) 22 (56.4)
Proxy reporting*
    Yes 88 (20.0) 22 (21.8) 16 (41.0) 0.01
    No 351 (80.0) 79 (78.2) 23 (59.0)
*

38 survivors of astroglial tumors have no information on surgery (28 with no vision loss, 8 with some vision loss, 2 with bilateral vision loss). 37 survivors of astroglial tumors have no information on chemotherapy or radiation (27 with no vision loss, 8 with some vision loss, 2 with bilateral vision loss). 8 survivors of astroglial tumor did not answer the question for the proxy reporting (7 with no vision loss, 1 with some vision loss).